Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors: Systematic Review and Meta-Analysis
- PMID: 37227327
- DOI: 10.1016/j.jcmg.2023.03.007
Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors: Systematic Review and Meta-Analysis
Abstract
Background: It is unclear whether detection and patient visualization of cardiovascular (CV) images using computed tomography to assess coronary artery calcium or carotid ultrasound (CU) to identify plaque and intima-medial thickness merely prompts prescription of lipid-lowering therapy or whether it motivates lifestyle change among patients.
Objectives: This systematic review and meta-analysis sought to investigate whether patient visualization of CV images (computed tomography or CU) has a beneficial impact on improving overall absolute CV risk as well as lipid and nonlipid CV risk factors in asymptomatic individuals.
Methods: The key words "CV imaging," "CV risk," "asymptomatic persons," "no known or diagnosed CV disease," and "atherosclerotic plaque" were searched in PubMed, Cochrane, and Embase in November 2021. Randomized trials that assessed the role of CV imaging in reducing CV risk in asymptomatic persons with no known CV disease were eligible for study inclusion. The primary outcome was a change in 10-year Framingham risk score from the trial commencement to the end of the follow-up following patient visualization of CV images.
Results: Six randomized controlled trials (7,083 participants) were included; 4 studies used coronary artery calcium and 2 used CU to detect subclinical atherosclerosis. All studies used image visualization in the intervention group to communicate CV risk. Imaging-guidance was associated with a 0.91% improvement in 10-year Framingham risk score (95% CI: 0.24%-1.58%; P = 0.01). Significant reductions in low-density-lipoprotein, total cholesterol, and systolic blood pressure were observed (all P < 0.05).
Conclusions: Patient visualization of CV imaging is associated with overall CV risk reduction and improvement of individual risk factors: cholesterol and systolic blood pressure.
Keywords: carotid ultrasound; coronary artery calcium; primary prevention; risk factors.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Supported in part by a grant from the Ernst Heine Foundation, Sydney, Australia. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Is a Picture Worth a Thousand Words?JACC Cardiovasc Imaging. 2023 Aug;16(8):1082-1084. doi: 10.1016/j.jcmg.2023.04.006. Epub 2023 May 31. JACC Cardiovasc Imaging. 2023. PMID: 37269270 No abstract available.
Similar articles
-
Influence of repeated plaque visualization on cardiovascular risk reduction after 3 years: a randomized controlled trial.Eur J Prev Cardiol. 2025 May 12;32(7):596-605. doi: 10.1093/eurjpc/zwae026. Eur J Prev Cardiol. 2025. PMID: 38243798 Clinical Trial.
-
Role of femoral artery ultrasound imaging in cardiovascular event risk prediction in a primary prevention cohort at a medium-term follow-up.J Cardiol. 2020 May;75(5):537-543. doi: 10.1016/j.jjcc.2019.09.012. Epub 2019 Oct 16. J Cardiol. 2020. PMID: 31629664
-
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial.Lancet. 2019 Jan 12;393(10167):133-142. doi: 10.1016/S0140-6736(18)32818-6. Epub 2018 Dec 3. Lancet. 2019. PMID: 30522919 Clinical Trial.
-
Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.Pharmacol Ther. 2022 Sep;237:108172. doi: 10.1016/j.pharmthera.2022.108172. Epub 2022 Mar 15. Pharmacol Ther. 2022. PMID: 35304222 Review.
-
Computed Tomography for Coronary Artery Calcification Scoring: Mammogram for the Heart.Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):529-36. doi: 10.1016/j.pcad.2016.01.007. Epub 2016 Feb 15. Prog Cardiovasc Dis. 2016. PMID: 26892393 Review.
Cited by
-
Role of the screening with coronary computed tomography angiography on lipid management and risk factors control in an asymptomatic Chinese population: a community-based, parallel-group, open-label, randomized clinical trial (RESPECT2).Trials. 2024 Sep 30;25(1):635. doi: 10.1186/s13063-024-08469-z. Trials. 2024. PMID: 39350195 Free PMC article.
-
Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review.Eur J Med Res. 2024 Mar 4;29(1):152. doi: 10.1186/s40001-024-01739-1. Eur J Med Res. 2024. PMID: 38438934 Free PMC article. Review.
-
CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy: A Nested Substudy of the SCOT-HEART 2 Randomized Clinical Trial.JAMA Cardiol. 2025 Aug 1;10(8):841-850. doi: 10.1001/jamacardio.2025.1763. JAMA Cardiol. 2025. PMID: 40531507 Clinical Trial.
-
The Role of Visualization in Estimating Cardiovascular Disease Risk: Scoping Review.JMIR Public Health Surveill. 2024 Oct 14;10:e60128. doi: 10.2196/60128. JMIR Public Health Surveill. 2024. PMID: 39401079 Free PMC article.
-
Impact of provision of abdominal aortic calcification results on fruit and vegetable intake: 12-week randomized phase 2 controlled trial.Nat Commun. 2024 Oct 14;15(1):8126. doi: 10.1038/s41467-024-52172-1. Nat Commun. 2024. PMID: 39402045 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical